19-55156942-C-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000363.5(TNNI3):​c.108+108G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.262 in 1,279,782 control chromosomes in the GnomAD database, including 54,530 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.37 ( 13201 hom., cov: 32)
Exomes 𝑓: 0.25 ( 41329 hom. )

Consequence

TNNI3
NM_000363.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -7.55

Publications

7 publications found
Variant links:
Genes affected
TNNI3 (HGNC:11947): (troponin I3, cardiac type) Troponin I (TnI), along with troponin T (TnT) and troponin C (TnC), is one of 3 subunits that form the troponin complex of the thin filaments of striated muscle. TnI is the inhibitory subunit; blocking actin-myosin interactions and thereby mediating striated muscle relaxation. The TnI subfamily contains three genes: TnI-skeletal-fast-twitch, TnI-skeletal-slow-twitch, and TnI-cardiac. This gene encodes the TnI-cardiac protein and is exclusively expressed in cardiac muscle tissues. Mutations in this gene cause familial hypertrophic cardiomyopathy type 7 (CMH7) and familial restrictive cardiomyopathy (RCM). Troponin I is useful in making a diagnosis of heart failure, and of ischemic heart disease. An elevated level of troponin is also now used as indicator of acute myocardial injury in patients hospitalized with moderate/severe Coronavirus Disease 2019 (COVID-19). Such elevation has also been associated with higher risk of mortality in cardiovascular disease patients hospitalized due to COVID-19. [provided by RefSeq, Aug 2020]
TNNI3 Gene-Disease associations (from GenCC):
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • dilated cardiomyopathy 2A
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • hypertrophic cardiomyopathy 7
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P
  • cardiomyopathy, familial restrictive, 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • dilated cardiomyopathy 1FF
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • dilated cardiomyopathy
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial isolated restrictive cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • arrhythmogenic right ventricular cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 19-55156942-C-G is Benign according to our data. Variant chr19-55156942-C-G is described in ClinVar as [Benign]. Clinvar id is 1245765.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.651 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TNNI3NM_000363.5 linkc.108+108G>C intron_variant Intron 3 of 7 ENST00000344887.10 NP_000354.4 P19429Q6FGX2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TNNI3ENST00000344887.10 linkc.108+108G>C intron_variant Intron 3 of 7 1 NM_000363.5 ENSP00000341838.5 P19429
ENSG00000267110ENST00000587871.1 linkn.*210+108G>C intron_variant Intron 6 of 8 5 ENSP00000473050.1 M0R381

Frequencies

GnomAD3 genomes
AF:
0.366
AC:
55528
AN:
151868
Hom.:
13161
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.657
Gnomad AMI
AF:
0.147
Gnomad AMR
AF:
0.404
Gnomad ASJ
AF:
0.214
Gnomad EAS
AF:
0.441
Gnomad SAS
AF:
0.441
Gnomad FIN
AF:
0.226
Gnomad MID
AF:
0.316
Gnomad NFE
AF:
0.201
Gnomad OTH
AF:
0.361
GnomAD4 exome
AF:
0.248
AC:
279347
AN:
1127796
Hom.:
41329
Cov.:
16
AF XY:
0.251
AC XY:
142031
AN XY:
566316
show subpopulations
African (AFR)
AF:
0.673
AC:
17824
AN:
26474
American (AMR)
AF:
0.481
AC:
16980
AN:
35286
Ashkenazi Jewish (ASJ)
AF:
0.215
AC:
5062
AN:
23496
East Asian (EAS)
AF:
0.421
AC:
14521
AN:
34512
South Asian (SAS)
AF:
0.412
AC:
30361
AN:
73780
European-Finnish (FIN)
AF:
0.231
AC:
8149
AN:
35216
Middle Eastern (MID)
AF:
0.327
AC:
1175
AN:
3596
European-Non Finnish (NFE)
AF:
0.202
AC:
171246
AN:
846214
Other (OTH)
AF:
0.285
AC:
14029
AN:
49222
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
10943
21886
32830
43773
54716
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5780
11560
17340
23120
28900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.366
AC:
55636
AN:
151986
Hom.:
13201
Cov.:
32
AF XY:
0.368
AC XY:
27314
AN XY:
74282
show subpopulations
African (AFR)
AF:
0.658
AC:
27239
AN:
41414
American (AMR)
AF:
0.405
AC:
6183
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.214
AC:
744
AN:
3470
East Asian (EAS)
AF:
0.441
AC:
2269
AN:
5144
South Asian (SAS)
AF:
0.441
AC:
2126
AN:
4826
European-Finnish (FIN)
AF:
0.226
AC:
2394
AN:
10576
Middle Eastern (MID)
AF:
0.306
AC:
90
AN:
294
European-Non Finnish (NFE)
AF:
0.201
AC:
13683
AN:
67966
Other (OTH)
AF:
0.367
AC:
774
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.519
Heterozygous variant carriers
0
1556
3112
4668
6224
7780
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
496
992
1488
1984
2480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.116
Hom.:
169
Bravo
AF:
0.392

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
0.015
DANN
Benign
0.33
PhyloP100
-7.6
PromoterAI
0.16
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3729838; hg19: chr19-55668310; COSMIC: COSV61276958; COSMIC: COSV61276958; API